Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Digestive Diseases and Sciences
Erschienen in: Digestive Diseases and Sciences 7/2019

07.02.2019 | Original Article

Blockage of the P2X7 Receptor Attenuates Harmful Changes Produced by Ischemia and Reperfusion in the Myenteric Plexus

verfasst von: Kelly Palombit, Cristina Eusébio Mendes, Wothan Tavares-de-Lima, Maria Luiza Barreto-Chaves, Patricia Castelucci

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Our work analyzed the effects of a P2X7 receptor antagonist, Brilliant Blue G (BBG), on rat ileum myenteric plexus following ischemia and reperfusion (ISR) induced by 45 min of ileal artery occlusion with an atraumatic vascular clamp with 24 h (ISR 24-h group) or 14 d of reperfusion (ISR 14-d group).

Material and methods

Either BBG (50 mg/kg or 100 mg/kg, BBG50 or BBG100 groups) or saline (vehicle) was administered subcutaneously 1 h after ischemia in the ISR 24-h group or once daily for the 5 d after ischemia in the ISR 14-d group (n = 5 per group). We evaluated the neuronal density and profile area by examining the number of neutrophils in the intestinal layers, protein expression levels of the P2X7 receptor, intestinal motility and immunoreactivity for the P2X7 receptor, nitric oxide synthase, neurofilament-200, and choline acetyl transferase in myenteric neurons.

Results

The neuronal density and profile area were restored by BBG following ISR. The ischemic groups showed alterations in P2X7 receptor protein expression and the number of neutrophils in the intestine and decreased intestinal motility, all of which were recovered by BBG treatment.

Conclusion

We concluded that ISR morphologically and functionally affected the intestine and that its effects were reversed by BBG treatment, suggesting the P2X7 receptor as a therapeutic target.
Literatur
1.
Furness JB. The enteric nervous system. Oxford: Blackwell; 2006.
2.
Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9:286–294.CrossRefPubMed
3.
Guan Y, Worrell RT, Pritts TA, Montrose MH. Intestinal ischemia–reperfusion injury: reversible and irreversible damage imaged in vivo. Am J Physiol Gastrointest Liver Physiol. 2009;297:187–196.CrossRef
4.
Haglund U, Bergqvist D. Intestinal ischemia—the basics. Langenbeck’s Arch Surg. 1999;384:233–238.CrossRef
5.
Oldenburg A, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia. A clinical review. Arc Intern Med. 2004;164:1054–1061.CrossRef
6.
7.
8.
9.
Marosti AR, da Silva MV, Palombit K, Mendes CE, Tavares-de-Lima W, Castelucci P. Differential effects of intestinal ischemia and reperfusion in rat enteric neurons and glial cells expressing P2X2 receptors. Histol Histopathol. 2015;30:489–501.PubMed
10.
11.
Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413–492.PubMed
12.
Burnstock G. A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L, eds. Cell membrane receptors for drugs and hormones. A multidisciplinary approach. New York: Raven Press; 1978:107–118.
13.
North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol. 2000;40:563–580.CrossRefPubMed
14.
15.
Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16:433–440.CrossRefPubMed
16.
Galligan JJ. Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil. 2002;14:611–623.CrossRefPubMed
17.
Abbrachio MP, Burnstock G, Verkhratsky A, Zimmermann H. Purinergic signaling in the nervous system: an overview. Trends Neurosci. 2009;32:19–29.CrossRef
18.
Burnstock G. Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal. 2014;10:3–50.CrossRefPubMed
19.
Franke H, Krüel U, Illes P. P2 receptors and neuronal injury. Euro J Physiol. 2006;452:622–644.CrossRef
20.
Sperlágh B, Illes P. P2X7 receptor, an emerging target in central nervous system diseases. Trends Pharmacol Sci. 2014;35:537–547.CrossRefPubMed
21.
Vulchanova L, Arvidsson U, Riedl M, et al. Differential distribution of two ATP-gated ion channels (P2X receptors) determined by immunohistochemistry. Proc Natl Acad Sci. 1996;93:8063–8067.CrossRefPubMed
22.
Hu HZ, Gao N, Lin Z, et al. P2X7 receptors in the enteric nervous system of guinea-pig small intestine. J Comp Neurol. 2001;440:299–310.CrossRefPubMed
23.
Castelucci P, Robbins HL, Poole DP, Furness JB. The distribution of purine P2X2 receptors in the guinea pig enteric nervous system. Histochem Cell Biol. 2002;117:415–422.CrossRefPubMed
24.
Poole DP, Castelucci P, Robbins HL, Chiocchetti R, Furness JB. The distribution of P2X3 purine receptor subunits in the guinea-pig enteric nervous system. Auton Neurosci. 2002;101:39–47.CrossRefPubMed
25.
Van Nassauw L, Brouns I, Adraensen D, Burnstock G, Timmermans JP. Neurochemical identification of enteric neurons expressing P2X(3) receptors in the guinea-pig ileum. Histochem Cell Biol. 2002;118:193–203.PubMed
26.
Xiang Z, Burnstock G. Distribution of P2Y2 receptors in the guinea pig enteric nervous system and its coexistence with P2X2 and P2X3 receptors, neuropeptide Y, nitric oxide synthase and calretinin. Histochem Cell Biol. 2005;124:379–390.CrossRefPubMed
27.
Xiang Z, Burnstock G. P2X2 and P2X3 purinoceptors in the rat enteric nervous system. Histochem Cell Biol. 2004;12:169–179.CrossRef
28.
Yu Q, Zhao Z, Sun J, Guo W, Fu J, Burnstock G. Expression of P2X6 receptors in the enteric nervous system of the rat gastrointestinal tract. Histochem Cell Biol. 2010;133:177–188.CrossRefPubMed
29.
Giaroni C, Knight GE, Ruan H-Z, et al. P2 receptors in the murine gastrointestinal tract. Neuropharmacology. 2002;43:1313–1323.CrossRefPubMed
30.
Ruan HZ, Burnstock G. The distribution of P2X5 purinergic receptors in the enteric nervous system of mouse. Cell Tissue Res. 2005;319:191–200.CrossRefPubMed
31.
Sperlágh B, Vizi ES, Wirkner K, Illes P. P2X7 receptors in the nervous system. Prog Neurobiol. 2006;78:327–346.CrossRefPubMed
32.
Burnstock G. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology. 2016;104:4–17.CrossRefPubMed
33.
Girotti PA, Misawa R, Palombit K, Mendes CE, Bittencourt JC, Castelucci P. Differential effects of undernourishment on the differentiation and maturation of rat enteric neurons. Cell Tissue Res. 2013;353:367–380.CrossRefPubMed
34.
Da Silva MV, Marosti AR, Mendes CE, Palombit K, Castelucci P. Differential effects of experimental ulcerative colitis on P2X7 receptor expression in enteric neurons. Histochem Cell Biol. 2015;143:171–184.CrossRefPubMed
35.
Da Silva MV, Marosti AR, Mendes CE, Palombit K, Castelucci P. Submucosal neurons and enteric glial cells expressing the P2X7 receptor in rat experimental colitis. Acta Histochem. 2017;119:481–494.CrossRefPubMed
36.
Wang X, Arcuino G, Takano T, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med. 2004;10:821–827.CrossRefPubMed
37.
Volonté C, Apolloni S, Skaper SD, Burnstock G. P2X7 receptors, channels, pores and more. CNS Neurol Disord Drug Targets. 2012;11:705–721.CrossRefPubMed
38.
Jiang LH, Mackenzie AB, North RA, Surprenant A. Brilliant Blue G selectively blocks ATP-gated rat P2X7 receptors. Mol Pharmacol. 2000;58:82–88.CrossRefPubMed
39.
Remy M, Thaler S, Schumann RG, et al. An in vivo evaluation of Brilliant Blue G in animals and humans. Br J Ophtalmol. 2008;92:1142–1147.CrossRef
40.
Ryu JK, Mclarnon JG. Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer’s disease. Neuroreport. 2008;19:1715–1719.CrossRefPubMed
41.
Díaz-Hernández M, Díez-Zaera M, Sánchez-Nogueiro J, et al. Altered P2X7-receptor level and function in mouse models of Huntington’s disease and therapeutic efficacy of antagonist administration. FASEB J. 2009;23:1893–1906.CrossRefPubMed
42.
Peng W, Cotrina ML, Han X, et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci. 2009;106:12489–12493.CrossRefPubMed
43.
Arbeloa J, Pérez-Samartín A, Gottlieb M, Matute C. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia. Neurobiol Dis. 2012;45:954–961.CrossRefPubMed
44.
Chu K, Yin B, Wang J, et al. Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus. J. Neuroinflamm. 2012;18:69–75.
45.
Rivera LR, Thacker M, Castelucci P, Poole DP, Frugier T, Furness JB. Knock out of neuronal nitric oxide synthase exacerbates intestinal ischemia/reperfusion injury in mice. Cell Tissue Res. 2012;349:565–576.CrossRefPubMed
46.
Franke H, Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther. 2006;109:297–324.CrossRefPubMed
47.
Gulbransen BD, Bashashati M, Hirota SA, et al. Activation of neuronal P2X7 receptor–pannexin-1 mediates death of enteric neurons during colitis. Nat Med. 2012;18:600–604.CrossRefPubMedPubMedCentral
48.
Roberts JA, Lukewich MK, Sharkey KA, Furness JB, Mawe GM, Lomax AE. The roles of purinergic signaling during gastrointestinal inflammation. Curr Opin Pharmacol. 2012;12:659–666.CrossRefPubMedPubMedCentral
49.
Antonioli L, Giron MC, Colucci R, et al. The role of purinergic pathways in the pathophysiology of gut diseases, pharmacological modulation and potential therapeutic applications. Pharmacol Ther. 2013;139:157–188.CrossRefPubMed
50.
Coutinho-Silva R, Persechini PM, Bisaggio RD, et al. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol. 1999;276:C1139–C1147.CrossRefPubMed
51.
Slater M, Barden JA, Murphy CR. The purinergic calcium channels P2X1,2,5,7 are down-regulated while P2X3,4,6 are up-regulated during apoptosis in the ageing rat prostate. Histochem J. 2000;32:571–580.CrossRefPubMed
52.
Castelucci P, De Souza RR, De Angelis RC, Furness JB, Liberti EA. Effects of pre- and postnatal protein deprivation and postnatal re-feeding on myenteric neurons of the rat large intestine: a quantitative morphological study. Cell Tissue Res. 2002;310:1–7.CrossRefPubMed
53.
Gomes OA, Castelucci P, Fontes RBV, Liberti EA. Effects of pre- and postnatal protein and postnatal re-feeding on myenteric neurons of the rat small intestine, a quantitative morphological study. Auton Neurosci. 2006;126:277–284.CrossRefPubMed
54.
Misawa R, Girotti PA, Mizuno MS, Liberti EA, Furness JB, Castelucci P. Effects of protein deprivation and re-feeding on P2X2 receptors in enteric neurons. World J Gastroenterol. 2010;16:3651–3663.CrossRefPubMedPubMedCentral
55.
Mizuno MS, Crisma AR, Borelli P, Castelucci P. Expression of the P2X2 receptor in different classes of ileum myenteric neurons in the female obese ob/ob mouse. World J Gastroenterol. 2012;18:4693–4703.CrossRefPubMedPubMedCentral
56.
Mizuno MS, Crisma AR, Borelli P, Schäfer BT, Silveira MP, Castelucci P. Distribution of the P2X2 receptor and chemical coding in ileal enteric neurons of obese male mice (ob/ob). World J Gastroenterol. 2014;20:13911–13919.CrossRefPubMedPubMedCentral
57.
Rivera LR, Thacker M, Castelucci P, Bron R, Furness JB. The reactions of specific neuron types to intestinal ischemia in the guinea pig enteric nervous system. Acta Neuropathol. 2009;118:261–270.CrossRefPubMed
58.
Fellin T, Pozzan T, Carmignoto G. Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes. J Biol Chem. 2006;281:4274–4284.CrossRefPubMed
59.
Kalff JC, Schraut WH, Simmons RL, Bauer AJ. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg. 1998;228:652–663.CrossRefPubMedPubMedCentral
60.
Hierholzer C, Kalff JC, Audolfsson G, et al. Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injury. Transplantation. 1999;68:1244–1254.CrossRefPubMed
61.
Massberg S, Messmer K. The nature of ischemia/reperfusion injury. Transplant Proc. 1998;30:4217–4223.CrossRefPubMed
62.
Filpa V, Carpanese E, Marchet S, et al. Nitric oxide regulates homeoprotein OTX1 and OTX2 expression in the rat myenteric plexus after intestinal ischemia–reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2017;312:G374–G389.CrossRefPubMed
63.
Pedata F, Dettori I, Coppi E, Melani A, Tweardy DJ, Bauer AJ. Purinergic signalling in brain ischemia. Neuropharmacology. 2016;104:105–130.CrossRefPubMed
64.
Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795–803.CrossRefPubMed
65.
Corriden R, Chen Y, Inoue Y, et al. GEcto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem. 2008;283:28480–28486.CrossRefPubMedPubMedCentral
66.
Di Virgilio F. Liaisons dangereuses, P2X(7) and the inflammasome. Trends Pharmacol Sci. 2007;28:465–472.CrossRefPubMed
67.
Csölle C, Sperlágh B. Peripheral origin of IL-1beta production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X(7) receptors. J Neuroimmunol. 2010;219:38–46.CrossRefPubMed
68.
Hassoun HT, Weisbrodt NW, Mercer DW, Kozar RA, Mooy FG, Moore FA. Inducible nitric oxide synthase mediates gut ischemia/reperfusion-induced ileus only after severe insults. J Surg Res. 2001;97:150–154.CrossRefPubMed
69.
Takahashi A, Tomomasa TH, Kaneko H, et al. Intestinal motility in an in vivo rat model of intestinal ischemia–reperfusion with special reference to the effects of nitric oxide on the motility changes. J Pediatr Gastroenterol Nutr. 2001;33:283–288.CrossRefPubMed
70.
Taha MO, Miranda-Ferreira R, Paez RP, et al. Role of l-arginine, a substrate of nitric oxide biosynthesis, on intestinal ischemia–reperfusion in rabbits. Transplant Proc. 2010;42:448–450.CrossRefPubMed
71.
Caplan MS, Hedlund E, Hill N, Mackendrick W. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenteroly. 1994;106:346–352.CrossRef
72.
Ragy M, Elbassuoni E. The role of nitric oxide and L-type calcium channel blocker in the contractility of rabbit ileum in vitro. J Physiol Biochem. 2012;68:521–528.CrossRefPubMed
73.
Ballabeni V, Barocelli E, Bertoni S, Impicciatore M. Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats. Life Sci. 2002;71:2025–2035.CrossRefPubMed
74.
Giaroni C, Marchet S, Carpanese E, et al. Role of neuronal and inducible nitric oxide synthases in the guinea pig ileum myenteric plexus during in vitro ischemia and reperfusion. Neurogastroenterol Motil. 2013;25:e114–e126.CrossRefPubMed
75.
Anitha M, Vijay-Kumar M, Sitaraman SV, Gewirtz AT, Srinivasan S. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology. 2012;143:1006.e4–1016.e4.CrossRef
76.
77.
Tran L, Greenwood-Van Meerveld B. In a non-human primate model, aging disrupts the neural control of intestinal smooth muscle contractility in a region-specific manner. Neurogastroenterol Motil. 2014;26:410–418.CrossRefPubMedPubMedCentral
Metadaten
Titel
Blockage of the P2X7 Receptor Attenuates Harmful Changes Produced by Ischemia and Reperfusion in the Myenteric Plexus
verfasst von
Kelly Palombit
Cristina Eusébio Mendes
Wothan Tavares-de-Lima
Maria Luiza Barreto-Chaves
Patricia Castelucci
Publikationsdatum
07.02.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05496-8

Weitere Artikel der Ausgabe 7/2019

Digestive Diseases and Sciences 7/2019 Zur Ausgabe

Review

New Face of Hepatitis C

Correction

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Original Article

Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn’s Disease and Untypical Intestinal Tuberculosis

Original Article

Personalized Inflammatory Bowel Disease Care Reduced Hospitalizations

Correspondence

CT in Crohn’s Disease Is Beneficial for Patient Care and Should Not Be Feared

Stanford Multidisciplinary Seminars

Open-and-Shut Case: An Uncommon Cause of GI Bleeding

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

17.04.2024 | DGIM 2024 | Nachrichten

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise